查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933339

安全採血針市場規模、佔有率、成長、全球產業分析：依類型、應用、區域洞察和預測（2026-2034 年）

Safety Lancets Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 請詢問到貨日

價格

安全採血針市場成長驅動因素

全球安全採血針市場規模在 2025 年預計將達到 12.1 億美元，2026 年將成長至 13.4 億美元，到 2034 年將達到 32.8 億美元，在預測期內複合年增長率 (CAGR) 將達到 11.81%。安全採血針是一種專用於血液採集的醫療器械，主要用於糖尿病管理和其他診斷應用。這些器械配備了安全功能，旨在保護醫護人員和患者，並最大限度地減少針刺傷。

糖尿病和其他慢性疾病的日益普遍、促進安全醫療實踐的技術創新以及監管壓力是推動市場成長的關鍵因素。 到 2025 年，北美將引領市場，佔全球 37.74% 的市場佔有率，這主要歸功於糖尿病的高發病率以及血糖監測產品的重要報銷計劃。

市場動態

驅動因素：糖尿病發生率的上升是安全採血針市場的主要驅動因素。根據健康指標與評估研究所 (IHME, 2023) 的數據顯示，全球有超過 5 億人患有糖尿病。人們對居家監測解決方案、便利性和微創採血方法的日益青睞進一步推動了市場需求。病人越來越重視舒適性和堅持定期檢測，這使得安全採血針成為有效疾病管理的重要工具。

限制因素：高昂的成本仍然是一個挑戰，尤其是在發展中地區。 安全採血針的價格通常為每100支4.87至5.06美元，而傳統採血針的價格為每100支2.37至4.22美元，這限制了價格敏感型醫護人員和病患的使用。

機會：家庭醫療監測的普及帶來了巨大的機會。全球範圍內，自我血糖監測（SMBG）正在興起。 2023年發表在 "印度醫學專科雜誌" 上的一項研究報告稱，35%的患者使用血糖儀在家進行SMBG。安全採血針易於使用，且針刺傷風險較低，因此非常適合家庭使用。

挑戰：發展中國家醫療保健支出的限制阻礙了市場成長。例如，孟加拉的醫療保健支出僅佔GDP的2.34%，公共醫療保健預算較低，阻礙了先進設備的廣泛應用。

市場趨勢

一個關鍵趨勢是向自動/壓力啟動式安全採血針的轉變。自動針頭回縮機制和降低損傷風險備受重視。研究表明，自動採血針可以減輕疼痛，並提高臨床和家庭護理的效率。

細分市場分析

依類型：

  • 依鈕式採血針佔主導地位，預計到2026年將佔62.57%的市場佔有率，這主要歸功於其易用性和簡單的啟動機制。
  • 壓力/觸摸式採血針可提供一致的穿刺深度和更高的安全性，因此在已開發地區越來越受歡迎。

依切口類型：

  • 針式採血針因其安全特性和減輕疼痛而佔主導地位。
  • 刀片式採血針的使用日益普及，尤其是在新生兒篩檢和乾血斑檢測領域，能夠採集更多血液樣本用於特定診斷。

依年齡組別劃分：

  • 由於血糖、糖化血紅素 (HbA1c) 和膽固醇檢測的頻率較高，成人是主要消費族群。
  • 兒科市場預計將迎來成長，這主要得益於第 1 型糖尿病監測和血糖自我監測 (SMBG) 的推廣。

依應用程式劃分：

  • 受糖尿病高發生率的推動，血糖監測預計將保持領先地位，到 2026 年市佔率將達到 59.67%。
  • 血紅素檢測預計將實現最快成長，而膽固醇檢測的普及率適中。
  • 其他應用包括血脂分析、凝血監測和乾血斑檢測。

依最終使用者劃分：

  • 預計到 2026 年，醫院和診所將保持領先地位，市場佔有率將達到 41.40%，這主要得益於患者就診量和輔助監測項目的普及。
  • 由於血糖自我監測 (SMBG) 的廣泛應用，家庭醫療保健預計將實現最高的複合年增長率 (CAGR)。
  • 其他市場包括血庫、診斷實驗室、學術機構和養老院。

區域展望

  • 北美：預計到 2025 年，該市場規模將達到 4.6 億美元，到 2026 年將達到 5.1 億美元，這主要得益於糖尿病的高發病率和強有力的報銷政策。
  • 歐洲：憑藉先進的醫療保健基礎設施，英國（2026年預計3000萬美元）和德國（2026年預計1億美元）是關鍵市場。
  • 亞太地區：得益於國內製造商和龐大的糖尿病人口，預計到2026年，日本（4000萬美元）、中國（1.5億美元）和印度（8000萬美元）將實現最高的複合年增長率。
  • 拉丁美洲：由於醫療保健支出增加和對家庭監測的需求不斷增長，預計該地區將實現成長。
  • 中東和非洲：由於糖尿病意識的提高和有利的政策，該地區預計將保持穩定成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要國家和地區主要疾病盛行率（2025 年）
  • 主要國家和地區自我血糖監測使用者數量（2025 年）
  • 安全採血針的進展
  • 概述：報銷方案
  • 主要產業趨勢（併購、合作）等等）

第五章 全球安全採血針市場分析、洞察與預測（2021-2034）

  • 市場分析、洞察與預測 - 依類型劃分
    • 依鈕式
    • 壓力/觸摸式
  • 市場分析、洞察與預測 - 依切口類型劃分
    • 針頭式
    • 刀片式
  • 市場分析、洞察與預測 - 依年齡組別劃分
    • 成人
    • 兒童
  • 市場分析、洞察與預測 - 依應用劃分
    • 血糖監測
    • 血紅素檢測
    • 膽固醇檢測
    • 其他
  • 市場分析、洞察與預測 - 依最終用途劃分用戶
    • 醫院和診所
    • 家庭醫療保健
    • 其他
  • 市場分析、洞察與預測 - 依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美安全採血針市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲安全採血針市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 美國王國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區安全採血針市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲安全採血針市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章中東與非洲安全採血針市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
    • BD
    • SARSTEDT AG &Co. KG
    • Greiner Bio-One International GmbH
    • HTL-STREFA (MTD Medical Technology and Devices)
    • Terumo Medical Corporation
    • B. Braun SE
    • Abbott
    • Cardinal Health
    • YPSOMED
    • Biosense Technologies Private Limited
Product Code: FBI113261

Growth Factors of safety lancets Market

The global safety lancets market was valued at USD 1.21 billion in 2025 and is projected to grow to USD 1.34 billion in 2026, reaching USD 3.28 billion by 2034, registering a robust CAGR of 11.81% during the forecast period. Safety lancets are specialized medical devices designed for blood sampling, primarily used for diabetes management and other diagnostic applications. These devices incorporate safety features to minimize accidental needle-stick injuries, enhancing protection for both healthcare providers and patients.

The growing prevalence of diabetes and other chronic diseases, along with technological innovations and regulatory pressures promoting safer medical practices, are key factors driving market growth. North America led the market in 2025, accounting for 37.74% of the global share, due to the high incidence of diabetes and significant reimbursement programs for blood glucose monitoring products.

Market Dynamics

Drivers: The increasing incidence of diabetes is a major driver of the safety lancets market. According to the Institute for Health Metrics and Evaluation (2023), over half a billion individuals globally are living with diabetes. The rising preference for home monitoring solutions, convenience, and less invasive blood sampling methods further propel demand. Patients increasingly seek comfort and compliance in regular testing routines, making safety lancets essential tools for effective disease management.

Restraints: High cost remains a challenge, especially in developing regions. Safety lancets typically cost USD 4.87-5.06 per 100 lancets, compared to USD 2.37-4.22 for traditional lancets, limiting adoption among price-sensitive healthcare providers and patients.

Opportunities: The growing trend of home healthcare monitoring presents significant opportunities. Self-monitoring of blood glucose (SMBG) is increasing globally; a 2023 study in the Indian Journal of Medical Specialties reported that 35% of patients used glucometers for SMBG at home. Safety lancets are well-suited for home use due to ease of use and reduced risk of needle-stick injuries.

Challenges: Limited healthcare spending in developing countries restricts market growth. Low public healthcare budgets, such as Bangladesh's 2.34% GDP expenditure on healthcare, hinder the availability and adoption of advanced devices.

Market Trends

A key trend is the shift toward automatic/pressure-activated safety lancets, favored for their automatic needle retraction and reduced risk of injury. Studies indicate that automatic lancets cause less pain and improve efficiency in both clinical and home care settings.

Segmentation Analysis

By Type:

  • Button-activated lancets dominate, holding 62.57% market share in 2026, due to ease of use and simple activation mechanisms.
  • Pressure/contact-activated lancets offer consistent puncture depth and enhanced safety, with increasing adoption in developed regions.

By Incision Type:

  • Needle lancets dominate due to safety features and reduced pain.
  • Blade lancets are growing, especially for neonatal screening and dried blood spot tests, providing higher blood volumes for certain diagnostics.

By Age Group:

  • Adults dominate due to frequent blood glucose, HbA1c, and cholesterol testing.
  • Pediatrics are witnessing growth due to type 1 diabetes monitoring and SMBG recommendations.

By Application:

  • Blood glucose monitoring leads with 59.67% market share in 2026, driven by diabetes prevalence.
  • Hemoglobin testing is projected for the fastest growth, while cholesterol testing shows moderate adoption.
  • Other applications include lipid profiling, coagulation monitoring, and dried blood spot tests.

By End-user:

  • Hospitals & clinics lead with 41.40% market share in 2026 due to patient visits and assisted monitoring programs.
  • Home care is expected to achieve the highest CAGR due to SMBG adoption.
  • Others include blood banks, diagnostic labs, academic institutions, and nursing homes.

Regional Outlook

  • North America: Market value of USD 0.46 billion in 2025, reaching USD 0.51 billion in 2026, driven by high diabetes prevalence and strong reimbursement policies.
  • Europe: Key markets include the U.K. (USD 0.03 billion in 2026) and Germany (USD 0.10 billion in 2026) due to advanced healthcare infrastructure.
  • Asia Pacific: Projected highest CAGR with Japan (USD 0.04 billion), China (USD 0.15 billion), and India (USD 0.08 billion) in 2026, supported by domestic manufacturers and large diabetic populations.
  • Latin America: Growth due to rising healthcare expenditure and home monitoring demand.
  • Middle East & Africa: Steady growth attributed to diabetes awareness and favorable policies.

Competitive Landscape

The market is highly fragmented, with major players such as BD, HTL-STREFA, Abbott, Cardinal Health, B. Braun SE, Terumo Medical Corporation, SARSTEDT AG & Co. KG, and YPSOMED focusing on product innovation, geographic expansion, and distribution partnerships. Key industry developments include product launches, national agreements, and participation in global medical exhibitions.

Conclusion

The global safety lancets market is poised for substantial growth, from USD 1.21 billion in 2025 to USD 3.28 billion by 2034, driven by rising diabetes prevalence, home monitoring adoption, and technological advancements in lancet safety. North America remains the dominant market, while Asia Pacific offers the highest growth potential. Although high costs and limited healthcare spending in some regions present challenges, the increasing focus on patient safety and convenient monitoring solutions positions the market for sustained expansion. Key players with strong R&D and distribution networks are expected to consolidate their leadership, shaping the competitive landscape in the coming years.

Segmentation By Type

  • Button-activated
  • Pressure/Contact-activated

By Incision Type

  • Needle
  • Blade

By Age Group

  • Adult
  • Pediatric

By Application

  • Blood Glucose Monitoring
  • Hemoglobin Testing
  • Cholesterol Testing
  • Others

By End-user

  • Hospitals & Clinics
  • Home Care
  • Others

By Region

  • North America (By Type, Incision Type, Age Group, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2025
  • 4.2. Number of SMBG User, By Key Countries/Region, 2025
  • 4.3. Advancements in Safety Lancets
  • 4.4. Overview: Reimbursement Scenario
  • 4.5. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)

5. Global Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Button-activated
    • 5.1.2. Pressure/Contact-activated
  • 5.2. Market Analysis, Insights and Forecast - By Incision Type
    • 5.2.1. Needle
    • 5.2.2. Blade
  • 5.3. Market Analysis, Insights and Forecast - By Age Group
    • 5.3.1. Adult
    • 5.3.2. Pediatric
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Blood Glucose Monitoring
    • 5.4.2. Hemoglobin Testing
    • 5.4.3. Cholesterol Testing
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & Clinics
    • 5.5.2. Home Care
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Button-activated
    • 6.1.2. Pressure/Contact-activated
  • 6.2. Market Analysis, Insights and Forecast - By Incision Type
    • 6.2.1. Needle
    • 6.2.2. Blade
  • 6.3. Market Analysis, Insights and Forecast - By Age Group
    • 6.3.1. Adult
    • 6.3.2. Pediatric
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Blood Glucose Monitoring
    • 6.4.2. Hemoglobin Testing
    • 6.4.3. Cholesterol Testing
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Home Care
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Button-activated
    • 7.1.2. Pressure/Contact-activated
  • 7.2. Market Analysis, Insights and Forecast - By Incision Type
    • 7.2.1. Needle
    • 7.2.2. Blade
  • 7.3. Market Analysis, Insights and Forecast - By Age Group
    • 7.3.1. Adult
    • 7.3.2. Pediatric
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Blood Glucose Monitoring
    • 7.4.2. Hemoglobin Testing
    • 7.4.3. Cholesterol Testing
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Home Care
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia pacific Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Button-activated
    • 8.1.2. Pressure/Contact-activated
  • 8.2. Market Analysis, Insights and Forecast - By Incision Type
    • 8.2.1. Needle
    • 8.2.2. Blade
  • 8.3. Market Analysis, Insights and Forecast - By Age Group
    • 8.3.1. Adult
    • 8.3.2. Pediatric
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Blood Glucose Monitoring
    • 8.4.2. Hemoglobin Testing
    • 8.4.3. Cholesterol Testing
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Home Care
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Button-activated
    • 9.1.2. Pressure/Contact-activated
  • 9.2. Market Analysis, Insights and Forecast - By Incision Type
    • 9.2.1. Needle
    • 9.2.2. Blade
  • 9.3. Market Analysis, Insights and Forecast - By Age Group
    • 9.3.1. Adult
    • 9.3.2. Pediatric
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Blood Glucose Monitoring
    • 9.4.2. Hemoglobin Testing
    • 9.4.3. Cholesterol Testing
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Home Care
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Lancets Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Button-activated
    • 10.1.2. Pressure/Contact-activated
  • 10.2. Market Analysis, Insights and Forecast - By Incision Type
    • 10.2.1. Needle
    • 10.2.2. Blade
  • 10.3. Market Analysis, Insights and Forecast - By Age Group
    • 10.3.1. Adult
    • 10.3.2. Pediatric
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Blood Glucose Monitoring
    • 10.4.2. Hemoglobin Testing
    • 10.4.3. Cholesterol Testing
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Home Care
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. BD
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. SARSTEDT AG & Co. KG
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Greiner Bio-One International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Terumo Medical Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. B. Braun SE
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Abbott
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Cardinal Health
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. YPSOMED
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Biosense Technologies Private Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1:Global Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2:Global Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 3:Global Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 4:Global Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5:Global Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 6:Global Safety Lancets Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7:North America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8:North America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 9:North America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 10:North America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11:North America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 12:North America Safety Lancets Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 15:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 16:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17:Europe Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 18:Europe Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 21:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 22:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 24:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 27:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 28:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 30:Latin America Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
  • Table 33:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 34:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 36:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1:Global Safety Lancets Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2:Global Safety Lancets Market Value Share (%), by Type, 2025 & 2034
  • Figure 3:Global Safety Lancets Market Value Share (%), by Incision Type, 2025 & 2034
  • Figure 4:Global Safety Lancets Market Value Share (%), by Age Group, 2025 & 2034
  • Figure 5:Global Safety Lancets Market Value Share (%), by Application, 2025 & 2034
  • Figure 6:Global Safety Lancets Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7:Global Safety Lancets Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8:North America Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 9:North America Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 10:North America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 11:North America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 12:North America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 13:North America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 14:North America Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15:North America Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 16:North America Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17:North America Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 18:North America Safety Lancets Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19:North America Safety Lancets Market Value Share (%), By Country, 2025
  • Figure 20:Europe Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 21:Europe Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 22:Europe Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 23:Europe Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 24:Europe Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 25:Europe Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 26:Europe Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27:Europe Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 28:Europe Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29:Europe Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 30:Europe Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 31:Europe Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 32:Asia Pacific Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 33:Asia Pacific Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 34:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 35:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 36:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 37:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 38:Asia Pacific Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39:Asia Pacific Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 40:Asia Pacific Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41:Asia Pacific Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 42:Asia Pacific Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 43:Asia Pacific Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 44:Latin America Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 45:Latin America Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 46:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 47:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 48:Latin America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 49:Latin America Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 50:Latin America Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51:Latin America Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 52:Latin America Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53:Latin America Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 54:Latin America Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 55:Latin America Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 56:Middle East & Africa Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
  • Figure 57:Middle East & Africa Safety Lancets Market Value Share (%), by Type, 2025
  • Figure 58:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 59:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2025
  • Figure 60:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 61:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2025
  • Figure 62:Middle East & Africa Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63:Middle East & Africa Safety Lancets Market Value Share (%), by Application, 2025
  • Figure 64:Middle East & Africa Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65:Middle East & Africa Safety Lancets Market Value Share (%), by End-user, 2025
  • Figure 66:Middle East & Africa Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
  • Figure 67:Middle East & Africa Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
  • Figure 68:Global Safety Lancets Market Share (%), By Company, 2025